BridgePath Scientific and CompliancePath, an Ideagen Company, Announce Strategic Teaming Agreement

This collaboration will leverage both companies' expertise to deliver innovative compliance and quality assurance solutions tailored for the life sciences industry.

FREDERICK, Md., Jan. 31, 2025 /PRNewswire-PRWeb/ -- BridgePath Scientific, a leading biotechnology solutions provider based in Frederick, Maryland, is excited to announce a strategic teaming agreement with CompliancePath, an Ideagen company headquartered in Philadelphia, PA. This collaboration will leverage both companies' expertise to deliver innovative compliance and quality assurance solutions tailored for the life sciences industry.

The teaming agreement will enhance BridgePath Scientific's capabilities offering services in regulatory compliance, quality management, and validation processes, enabling the company to provide comprehensive support for biotechnology firms and laboratories navigating complex regulatory landscapes.

CompliancePath, a renowned expert in quality systems and compliance frameworks, brings extensive experience in regulated industries, ensuring clients meet stringent standards in computer system validation, IT governance, quality system services such as QMS administration and regulatory submissions supporting medical devices, software as a medical device, and pharmaceutical.

"We are thrilled to partner with CompliancePath, a company known for its excellence in compliance and risk management," said Patrick Haley, CEO of BridgePath Scientific. "This collaboration strengthens our ability to support our clients in achieving regulatory compliance, while continuing to deliver the highest level of service and innovation."

Jeff Smolley from CompliancePath added, "Our mission aligns perfectly with BridgePath's commitment to providing solutions that enhance efficiency and regulatory compliance. Together, we will offer unparalleled services to ensure that our clients remain at the forefront of scientific and regulatory excellence."

Through this partnership, both companies aim to deliver scalable, compliant, and secure solutions to clients across the life sciences sector. With a focus on data integrity and regulatory compliance, the teaming agreement positions BridgePath and CompliancePath to expand their service offerings and meet the evolving needs of the industry.

Media Contact

Patrick Haley, BridgePath Scientific, 301-305-8604, [email protected], www.bridgepathsci.com 

Jeff Smolley, CompliancePath, an Ideagen Company, 301-325-2341, [email protected], www.compliancepath.com 

View original content:https://www.prweb.com/releases/bridgepath-scientific-and-compliancepath-an-ideagen-company-announce-strategic-teaming-agreement-302364998.html

SOURCE BridgePath Scientific